It is a pharma private limited company based in Jagadhri, Haryana, India, established in 2021.
2021 | Jagadhri, Haryana, India | ActiveNeckin Bioremedies Private Limited, a active private limited company, was established on 08 July 2021 in Jagadhri, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24110HR2021PTC096165. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Sanjay Kumar (Director), Surjeet Sharma (Director), Ashish (Additional Director). It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ground Floor, Part-1, 75,Sector-17 Huda, Near By Jindal Hospital, Jagadhri, Haryana, 135003.
U24110HR2021PTC096165
096165
08 July 2021
₹1.50 M
₹1.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Neckin Bioremedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Kumar | Director | 08 Jul 2021 | Current |
| Surjeet Sharma | Director | 08 Jul 2021 | Current |
| Ashish | Additional Director | 10 Jun 2024 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neckin Bioremedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 304.76% increase. The company also saw a substantial improvement in profitability, with a 70118.42% increase in profit. The company's net worth moved up by a moderate rise of 7.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Neckin Bioremedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2023 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Neckin Bioremedies has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Neckin Bioremedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neckin Bioremedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Neckin Bioremedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Ashish was appointed as a Additional Director was appointed as a Additional Director on 10 Jun 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
Neckin Bioremedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.00 M with Charge ID 100791724 was registered on 15 Sep 2023. was completed.
Progress on Sanjay Kumar was appointed as a Director was appointed as a Director on 08 Jul 2021 & has been associated with this company since 4 years 4 months . was documented.
The activity Surjeet Sharma was appointed as a Director was appointed as a Director on 08 Jul 2021 & has been associated with this company since 4 years 4 months . was completed.
The CIN of Neckin Bioremedies Private Limited is U24110HR2021PTC096165.
Neckin Bioremedies Private Limited is headquartered at Ground Floor, Part-1, 75,Sector-17 Huda, Near By Jindal Hospital, Jagadhri, Haryana, 135003.
Neckin Bioremedies Private Limited was incorporated on 08 July 2021.
The current directors of Neckin Bioremedies Private Limited are
The primary industry of Neckin Bioremedies Private Limited is Trade.
Neckin Bioremedies Private Limited is unlisted.
The authorized capital of Neckin Bioremedies Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX